Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIOGEN | 8 | 54 | +3,27 % | ||
| BIONTECH | 8 | 13 | +1,83 % | ||
| COMPASS PATHWAYS | 6 | 11 | +40,35 % | ||
| ANI PHARMACEUTICALS | 5 | 5 | +1,46 % | ||
| BRIDGEBIO PHARMA | 5 | - | -0,40 % | ||
| LEGEND BIOTECH | 4 | - | +15,56 % | ||
| ATAIBECKLEY | 4 | - | +24,56 % | ||
| AMGEN | 3 | 27 | -1,31 % | ||
| GILEAD SCIENCES | 3 | 5 | -1,73 % | ||
| BICYCLE THERAPEUTICS | 3 | 5 | +0,44 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22:30 | FDA grants fast track status to BridgeBio's pancreatic cancer drug | 1 | Investing.com | ||
| 22:12 | Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 3 | GlobeNewswire (USA) | ||
| 22:12 | Trevi Therapeutics, Inc.: Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares | 4 | GlobeNewswire (USA) | ||
| 22:09 | EQS-News: ABIVAX: Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents | 181 | EQS Group (EN) | EQS-News: ABIVAX
/ Key word(s): AGM/EGM
Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents
20.04.2026 /... ► Artikel lesen | |
| 22:06 | Cytokinetics, Incorporated: Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) | 4 | GlobeNewswire (USA) | ||
| 21:46 | Leerink senkt Kursziel für Arcus Biosciences nach Ende der Gilead-Kooperation | 13 | Investing.com Deutsch | ||
| 21:42 | Leerink cuts Arcus Biosciences stock price target on Gilead collaboration end | 2 | Investing.com | ||
| 21:26 | AACR: Endeavoring to go global, Zai Lab offers reality check on China's biotech ascent | 1 | FierceBiotech | ||
| 21:08 | Abivax S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 21:05 | Trump Sends Compass Pathways Stock Soaring as He Backs Psychedelics. Should You Buy CMPS Here? | 4 | Barchart.com | ||
| 20:24 | Kyverna rises on new mid-stage trial data for myasthenia gravis therapy | 8 | Seeking Alpha | ||
| 19:30 | AnaptysBio rises after completing First Tracks spinoff | 5 | Seeking Alpha | ||
| 19:27 | Here's Why Agios Pharmaceuticals Crashed 23% Today | 8 | The Motley Fool | ||
| 19:18 | Stifel reiterates Tango Therapeutics stock rating on combo potential | 1 | Investing.com | ||
| 19:10 | Stifel bestätigt Kaufempfehlung für Tango Therapeutics wegen Kombinationspotenzial | 9 | Investing.com Deutsch | ||
| 18:35 | Biogen Earnings Preview: What to Expect | 5 | Barchart.com | ||
| 18:27 | Why Compass Pathways Stock Rocketed 40% Today | 8 | The Motley Fool | ||
| 18:12 | Biogen to buy China rights to immune disease drug for up to $850M | 2 | Seeking Alpha | ||
| 18:10 | Neurogene hires new CCO as it eyes commercial future for its Rett gene therapy | 1 | FiercePharma | ||
| 18:06 | Jefferies reiterates Erasca stock Buy rating ahead of ASCO data | 1 | Investing.com |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.